摘要
目的:探讨肝硬化腹水患者临床治疗的药学监护,为优化临床药物治疗提供参考。方法:临床药师参与1例肝硬化腹水患者临床治疗的全过程,制订相应的药学监护计划,根据治疗效果和病情变化针对性提出用药建议,并对患者进行用药教育。结果:临床药师参与肝硬化腹水患者的临床用药制订,提高了肝硬化患者用药的安全性、有效性、依从性,改善了患者的病情。结论:临床药师在治疗肝硬化腹水的过程中参与临床会诊,为其制订个体化用药方案,提高了肝硬化腹水患者治疗的治愈率。
Objective：To investigate the pharmaceutical care of clinical therapy of patients with ascites due to cirrhosis and to optimize the clinical drug therapy. Methods：The clinical pharmacists involved a case of ascites due to cirrhosis clinical care process, developed in appropriate pharmaceutical care plan and made adjusted medication recommendations according to patient＇s personal conditions, and gave medication education for patient. Results：The clinical pharmacist involved in clinical medication therapy for patients with liver cirrhosis, improved the safety, effectiveness and compliance of drug therapy, and improved the patient＇s status. Conclusion：Clinical pharmacists participate in clinical treatment of ascites due to cirrhosis, develop personalized medication programs for patient, improve the clinical medication safety, validity and rationality and finally, ensure patient safety in medication.
出处
《抗感染药学》
2013年第4期281-285,共5页
Anti-infection Pharmacy
关键词
肝硬化腹水
临床药师
药学监护
cirrhosis with ascites
Clinical pharmacist
Pharmaceutical care
